--- title: "BeOne Medicines and partners renew Brukinsa access programme for CLL" type: "News" locale: "en" url: "https://longbridge.com/en/news/296331290.md" description: "BeOne Medicines and The Max Foundation have renewed their partnership to expand access to Brukinsa for chronic lymphocytic leukemia (CLL) patients. Building on a program that has already treated over 300 patients in Armenia, Ethiopia, and Nepal, the renewed agreement aims to reach approximately 1,000 patients cumulatively. Supported by donated drug and a $1m grant, the initiative will continue support in existing countries and potentially expand to others like Côte d’Ivoire and Malawi, ensuring ongoing treatment beyond 2028 if clinically required." datetime: "2026-08-19T07:49:37.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296331290.md) - [en](https://longbridge.com/en/news/296331290.md) - [zh-HK](https://longbridge.com/zh-HK/news/296331290.md) generator: "portal-rs" --- # BeOne Medicines and partners renew Brukinsa access programme for CLL A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser. ### Related Stocks - [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md) - [ONC.US](https://longbridge.com/en/quote/ONC.US.md) - [06160.HK](https://longbridge.com/en/quote/06160.HK.md) ## Related News & Research - [BeOne Medicines Grants RSUs to 235 Employees Under Incentive Plan](https://longbridge.com/en/news/298025672.md) - [FDA Approves Tablet Form of Zanubrutinib for All Approved Indications](https://longbridge.com/en/news/298434766.md) - [Arm CEO says AI could cure cancer. Data centers are creating a bottleneck.](https://longbridge.com/en/news/298273784.md) - [Arm expands Total Design program to physical AI with 80-plus ecosystem partners](https://longbridge.com/en/news/298248556.md) - [AI Could Eventually Crack Cancer and Drug Discovery, Says Arm CEO — But This Is What’s Holding It Back](https://longbridge.com/en/news/298315170.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**